Location History:
- Marseille, FR (2003)
- Marseilles, FR (2000 - 2011)
Company Filing History:
1 out of 870 
1 out of 21 
1 out of 5,101 
Years Active: 2000-2011
Title: Genevieve Rougon: Innovator in Neurodegenerative Disease Treatment
Introduction
Genevieve Rougon is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and patented inventions. With a total of 4 patents, Rougon's work focuses on the modulation of neural functions and the treatment of various injuries.
Latest Patents
One of her latest patents involves the use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions. This patent describes a peptide consisting of 5 to 30 amino acid residues, preferably 9 to 15, most preferably about 12 amino acid residues. The peptide comprises a B epitope of a poly-α2,8 sialic acid attached to NCAM, which is recognized by an anti-poly-α2,8 sialic acid (PSA) antibody. The invention aims to prepare a medicament for modulating NCAM functions, which can be administered for the prevention and treatment of neurodegenerative diseases, brain and spine lesions, age-related learning and memory problems, and cancer. Another significant patent focuses on the KAL protein, identified as the active agent in a therapeutic composition for treating nerve tissue injuries, including spinal cord tissue. This therapeutic agent can be administered locally or intravenously and is also effective in treating retinal disorders.
Career Highlights
Throughout her career, Rougon has worked with notable institutions, including the Institut Pasteur. Her research has led to advancements in understanding and treating complex neurological conditions.
Collaborations
Genevieve Rougon has collaborated with esteemed colleagues such as Christine Petit and Nadia Soussi-Yanticostas, contributing to a rich exchange of ideas and innovations in her field.
Conclusion
Genevieve Rougon's contributions to the field of neurodegenerative disease treatment through her patents and research collaborations highlight her as a key figure in medical innovation. Her work continues to pave the way for new therapeutic approaches to complex neurological issues.